AIM ImmunoTech (UK) Today
| 0A4Y Stock | 0.22 0.01 4.76% |
Performance0 of 100
| Odds Of DistressOver 65
|
AIM ImmunoTech is selling for under 0.22 as of the 27th of November 2024; that is 4.76% up since the beginning of the trading day. The stock's lowest day price was 0.22. AIM ImmunoTech has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for AIM ImmunoTech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Business Domain Energy |
AIM ImmunoTech is entity of United Kingdom. It is traded as Stock on LSE exchange. More on AIM ImmunoTech
Moving together with AIM Stock
| 0.89 | SMSD | Samsung Electronics | PairCorr |
| 0.92 | SMSN | Samsung Electronics | PairCorr |
| 0.67 | HYUD | Hyundai Motor | PairCorr |
Moving against AIM Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
AIM Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AIM ImmunoTech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AIM ImmunoTech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Chairman | Esq JD |
| Thematic Idea | IT (View all Themes) |
| Business Concentration | Oil, Gas & Consumable Fuels, Energy, IT, Energy, Oil, Gas & Consumable Fuels, Energy, Energy, Computing (View all Sectors) |
AIM ImmunoTech (0A4Y) is traded on London Exchange in UK and employs 26 people. AIM ImmunoTech is listed under Oil, Gas & Consumable Fuels category by Fama And French industry classification. The company operates under Oil, Gas & Consumable Fuels sector and is part of Energy industry.
Check AIM ImmunoTech Probability Of Bankruptcy
Ownership AllocationAIM ImmunoTech shows 8.57 percent of its outstanding shares held by insiders and 14.07 percent owned by other corporate entities.
Check AIM Ownership Details
AIM ImmunoTech Risk Profiles
Although AIM ImmunoTech's alpha and beta are two of the key measurements used to evaluate AIM ImmunoTech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.81 | |||
| Standard Deviation | 4.79 | |||
| Variance | 22.95 | |||
| Risk Adjusted Performance | (0.1) |
AIM Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AIM ImmunoTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
AIM ImmunoTech Corporate Executives
Elected by the shareholders, the AIM ImmunoTech's board of directors comprises two types of representatives: AIM ImmunoTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AIM. The board's role is to monitor AIM ImmunoTech's management team and ensure that shareholders' interests are well served. AIM ImmunoTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AIM ImmunoTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.